FDA approves cancer drug without proof it extends life

FDA approves deadly cancer drug without proof it works

If you’ve ever had to face a cancer diagnosis, I can bet you told yourself three words: Whatever it takes.

You vowed to yourself that you’d do anything possible to defeat this deadly disease, but mainstream medicine has only ever offered very few options – and they all sound like they belong in a supervillain’s torture chamber.

Mutilation…toxic radiation…sickening chemicals…you can almost hear the wicked laughter that accompanies your “cure.”

Big Pharma knows you’re willing to suffer through the most agonizing of treatments, if it means you can beat this thing. They’ve pegged you as desperate. That is why drug companies are able to bring to market an expensive, unproven cancer drug like Afinitor and turn it into a money-making blockbuster.

But if your doctor ever asks you to start taking Afinitor, it’s time to draw the line.

Because the same medicine that’s supposed to save your life could end up shortening it – in a painful, crippling way. And thanks to the yahoos at the FDA, more people are being tormented by this worthless and harmful drug than ever before.

You see, the FDA gave this medicine the green light in 2009, even though there was no proof that it extends life. The drug, like most cancer drugs, is approved on so-called “surrogate measures” that simply extrapolate certain data, rather than wait for the actual health outcomes. Surrogate measures use faster, smaller and cheaper clinical trials.

Since its initial approval the drug has won FDA approval for a new use FIVE times since then – still without any credible scientific evidence to back it up.

Only the FDA would take a risky, patient-killer like Afinitor and keep expanding its use each year!

As a result, the drug’s manufacturer Novartis will push its sales of the drug from $110 million in 2010 to an estimated $1.6 billion this year.

But it could be deadly for you or your loved ones. This may be one of the most useless and dangerous drugs to come down the pike with the FDA’s approval.

In the six years since it hit the market, there have been nearly 9,000 reports of serious adverse reactions among Afinitor users, including more than 2,700 deaths!

Even Novartis’ own research shows what a dangerous dud this thing is. In the trial for advanced breast cancer, 63 percent had to cut the dose or stop treatment all together. And one in five patients developed a potentially fatal lung condition in which their body became deprived of oxygen. Without oxygen, your brain, liver and other organs can be damaged in just minutes.

The drug also comes with a long list of other serious debilitating side-effects. In clinical trials, at least 30 percent wound up with mouth sores, infections, headache, cough, abdominal pain, or diarrhea.

Need another reason to NOT take Afinitor? Oh, maybe because it’s priced at just $450 a pill – or about $11,000 a year.

Why? Because it’s easy and the mainstream drug industry knows that people with cancer are at the end of their rope. And the lucky ones are those who can’t afford the pretty penny this prescription will cost them.

So, if you or a loved one is diagnosed with cancer, and the doctor mentions the word Afinitor, do whatever it takes…to say no thanks, and seek better advice elsewhere.

Sources:

FDA repeatedly approved cancer drug Afinitor without proof it extended life

(jsonline.com)